Zobrazeno 1 - 10
of 3 255
pro vyhledávání: '"Morrison DK"'
Autor:
Spencer-Smith R; Laboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer Institute-Frederick, Frederick, MD 21702, U.S.A., Morrison DK; Laboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer Institute-Frederick, Frederick, MD 21702, U.S.A.
Publikováno v:
Biochemical Society transactions [Biochem Soc Trans] 2024 Jun 26; Vol. 52 (3), pp. 1061-1069.
Autor:
Spencer-Smith R; Laboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer Institute-Frederick, Frederick, MD 21702, USA. Electronic address: smithrs@mail.nih.gov., Morrison DK; Laboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer Institute-Frederick, Frederick, MD 21702, USA. Electronic address: morrisod@mail.nih.gov.
Publikováno v:
STAR protocols [STAR Protoc] 2023 Sep 15; Vol. 4 (3), pp. 102461. Date of Electronic Publication: 2023 Aug 16.
Autor:
Spencer-Smith R; Laboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer Institute-Frederick, Frederick, MD 21702 USA., Terrell EM; Laboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer Institute-Frederick, Frederick, MD 21702 USA., Insinna C; Laboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer Institute-Frederick, Frederick, MD 21702 USA., Agamasu C; National Cancer Institute RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD 21702 USA., Wagner ME; National Cancer Institute RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD 21702 USA., Ritt DA; Laboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer Institute-Frederick, Frederick, MD 21702 USA., Stauffer J; Laboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer Institute-Frederick, Frederick, MD 21702 USA., Stephen AG; National Cancer Institute RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD 21702 USA., Morrison DK; Laboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer Institute-Frederick, Frederick, MD 21702 USA. Electronic address: morrisod@mail.nih.gov.
Publikováno v:
Molecular cell [Mol Cell] 2022 Nov 17; Vol. 82 (22), pp. 4262-4276.e5. Date of Electronic Publication: 2022 Nov 07.
Autor:
Senadeera SPD; Molecular Targets Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702-1201, United States., Wang D; Molecular Targets Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702-1201, United States., Kim CK; Molecular Targets Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702-1201, United States., Smith EA; Molecular Targets Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702-1201, United States.; Basic Science Program, Leidos Biomedical Research, Inc., Frederick National Laboratory of Cancer Research, Frederick, Maryland 21702-1201, United States., Durrant DE; Laboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702-1201, United States., Alexander PA; National Cancer Institute RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland 21701, United States., Wendt KL; Department of Chemistry and Biochemistry, Stephenson Life Sciences Research Center, and Natural Products Discovery Group and Institute for Natural Products Applications and Research Technologies, University of Oklahoma, Norman, Oklahoma 73019, United States., Stephen AG; National Cancer Institute RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland 21701, United States., Morrison DK; Laboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702-1201, United States., Cichewicz RH; Department of Chemistry and Biochemistry, Stephenson Life Sciences Research Center, and Natural Products Discovery Group and Institute for Natural Products Applications and Research Technologies, University of Oklahoma, Norman, Oklahoma 73019, United States., Henrich CJ; Molecular Targets Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702-1201, United States.; Basic Science Program, Leidos Biomedical Research, Inc., Frederick National Laboratory of Cancer Research, Frederick, Maryland 21702-1201, United States., Beutler JA; Molecular Targets Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702-1201, United States.
Publikováno v:
Journal of natural products [J Nat Prod] 2022 Jun 24; Vol. 85 (6), pp. 1603-1616. Date of Electronic Publication: 2022 Jun 13.
Autor:
Murphy BM; Department of Cancer Biology and Genetics, The Ohio State University, Columbus, OH, 43210, USA., Terrell EM; Laboratory of Cell and Developmental Signaling, National Cancer Institute-Frederick, Frederick, MD, 21702, USA., Chirasani VR; Department of Biochemistry & Biophysics and Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA., Weiss TJ; Department of Cancer Biology and Genetics, The Ohio State University, Columbus, OH, 43210, USA., Lew RE; Department of Cancer Biology and Genetics, The Ohio State University, Columbus, OH, 43210, USA.; Department of Molecular Genetics, The Ohio State University, Columbus, OH, 43210, USA., Holderbaum AM; Department of Cancer Biology and Genetics, The Ohio State University, Columbus, OH, 43210, USA.; Department of Molecular Genetics, The Ohio State University, Columbus, OH, 43210, USA., Dhakal A; Department of Molecular Genetics, The Ohio State University, Columbus, OH, 43210, USA., Posada V; Department of Molecular Genetics, The Ohio State University, Columbus, OH, 43210, USA., Fort M; Department of Molecular Genetics, The Ohio State University, Columbus, OH, 43210, USA., Bodnar MS; Department of Cancer Biology and Genetics, The Ohio State University, Columbus, OH, 43210, USA.; Department of Molecular Genetics, The Ohio State University, Columbus, OH, 43210, USA., Carey LM; Department of Biochemistry & Biophysics and Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA., Chen M; Department of Cancer Biology and Genetics, The Ohio State University, Columbus, OH, 43210, USA.; Genetically Engineered Mouse Modeling Core, The Ohio State University, Columbus, OH, 43210, USA., Burd CJ; Department of Molecular Genetics, The Ohio State University, Columbus, OH, 43210, USA., Coppola V; Department of Cancer Biology and Genetics, The Ohio State University, Columbus, OH, 43210, USA.; Genetically Engineered Mouse Modeling Core, The Ohio State University, Columbus, OH, 43210, USA., Morrison DK; Laboratory of Cell and Developmental Signaling, National Cancer Institute-Frederick, Frederick, MD, 21702, USA., Campbell SL; Department of Biochemistry & Biophysics and Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA., Burd CE; Department of Cancer Biology and Genetics, The Ohio State University, Columbus, OH, 43210, USA. burd.25@osu.edu.; Department of Molecular Genetics, The Ohio State University, Columbus, OH, 43210, USA. burd.25@osu.edu.
Publikováno v:
Nature communications [Nat Commun] 2022 Jun 07; Vol. 13 (1), pp. 3153. Date of Electronic Publication: 2022 Jun 07.
Autor:
Simanshu DK; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland., Morrison DK; Laboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer Institute, Frederick, Maryland.
Publikováno v:
Cancer discovery [Cancer Discov] 2022 Apr 01; Vol. 12 (4), pp. 899-912.
Autor:
Johnson CW; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Brigham & Women's Hospital and Harvard Medical School, Boston, MA 02115, USA., Seo HS; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Biological Chemistry & Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA., Terrell EM; Laboratory of Cell and Developmental Signaling, NCI-Frederick, Frederick, MD 21702, USA., Yang MH; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Brigham & Women's Hospital and Harvard Medical School, Boston, MA 02115, USA., KleinJan F; Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada., Gebregiworgis T; Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada., Gasmi-Seabrook GMC; Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada., Geffken EA; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Lakhani J; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Song K; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Bashyal P; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Popow O; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Brigham & Women's Hospital and Harvard Medical School, Boston, MA 02115, USA; Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA., Paulo JA; Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA., Liu A; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Mattos C; Department of Chemistry and Chemical Biology, Northeastern University, Boston, MA 02115, USA., Marshall CB; Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada., Ikura M; Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada., Morrison DK; Laboratory of Cell and Developmental Signaling, NCI-Frederick, Frederick, MD 21702, USA., Dhe-Paganon S; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Biological Chemistry & Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA., Haigis KM; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Brigham & Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. Electronic address: Kevin_Haigis@dfci.harvard.edu.
Publikováno v:
Molecular cell [Mol Cell] 2022 Mar 03; Vol. 82 (5), pp. 950-968.e14. Date of Electronic Publication: 2022 Feb 23.
Autor:
Martinez Fiesco JA; Center for Structural Biology, Center for Cancer Research, National Cancer Institute-Frederick, Frederick, MD, 21702, USA., Durrant DE; Laboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer Institute-Frederick, Frederick, MD, 21702, USA., Morrison DK; Laboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer Institute-Frederick, Frederick, MD, 21702, USA. morrisod@mail.nih.gov., Zhang P; Center for Structural Biology, Center for Cancer Research, National Cancer Institute-Frederick, Frederick, MD, 21702, USA. ping.zhang@nih.gov.
Publikováno v:
Nature communications [Nat Commun] 2022 Jan 25; Vol. 13 (1), pp. 486. Date of Electronic Publication: 2022 Jan 25.
Autor:
Durrant DE; Laboratory of Cell and Developmental Signaling, NCI, Frederick, Maryland., Smith EA; Molecular Targets Program, Center of Cancer Research, NCI, Frederick, Maryland.; Basic Research Program, Leidos Biomedical Research, Inc., Frederick, Maryland., Goncharova EI; Molecular Targets Program, Center of Cancer Research, NCI, Frederick, Maryland.; Biomedical Informatics and Data Science Directorate, NCI, Frederick, Maryland., Sharma N; Molecular Targets Program, Center of Cancer Research, NCI, Frederick, Maryland., Alexander PA; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland., Stephen AG; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland., Henrich CJ; Molecular Targets Program, Center of Cancer Research, NCI, Frederick, Maryland. morrisod@mail.nih.gov curtis.henrich2@nih.gov.; Basic Research Program, Leidos Biomedical Research, Inc., Frederick, Maryland., Morrison DK; Laboratory of Cell and Developmental Signaling, NCI, Frederick, Maryland. morrisod@mail.nih.gov curtis.henrich2@nih.gov.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2021 Sep; Vol. 20 (9), pp. 1743-1754. Date of Electronic Publication: 2021 Jun 22.
Autor:
Torres-Ayuso P; Laboratory of Cell and Developmental Signaling, Center for Cancer Research, NCI, Frederick, Maryland. john.brognard@nih.gov torresayusop2@nih.gov., An E; Laboratory of Cell and Developmental Signaling, Center for Cancer Research, NCI, Frederick, Maryland., Nyswaner KM; Laboratory of Cell and Developmental Signaling, Center for Cancer Research, NCI, Frederick, Maryland., Bensen RC; Laboratory of Cell and Developmental Signaling, Center for Cancer Research, NCI, Frederick, Maryland., Ritt DA; Laboratory of Cell and Developmental Signaling, Center for Cancer Research, NCI, Frederick, Maryland., Specht SI; Laboratory of Cell and Developmental Signaling, Center for Cancer Research, NCI, Frederick, Maryland., Das S; Protein Characterization Laboratory, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Andresson T; Protein Characterization Laboratory, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Cachau RE; Advanced Biomedical Computational Science, Biomedical Informatics and Data Science, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Liang RJ; Laboratory of Cell and Developmental Signaling, Center for Cancer Research, NCI, Frederick, Maryland., Ries AL; Laboratory Animal Sciences Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Robinson CM; Laboratory Animal Sciences Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Difilippantonio S; Laboratory Animal Sciences Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Gouker B; Molecular Histopathology Laboratory, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Bassel L; Molecular Histopathology Laboratory, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Karim BO; Molecular Histopathology Laboratory, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Miller CJ; Department of Pharmacology, Yale School of Medicine, New Haven, Connecticut., Turk BE; Department of Pharmacology, Yale School of Medicine, New Haven, Connecticut., Morrison DK; Laboratory of Cell and Developmental Signaling, Center for Cancer Research, NCI, Frederick, Maryland., Brognard J; Laboratory of Cell and Developmental Signaling, Center for Cancer Research, NCI, Frederick, Maryland. john.brognard@nih.gov torresayusop2@nih.gov.
Publikováno v:
Cancer discovery [Cancer Discov] 2021 Jun; Vol. 11 (6), pp. 1411-1423. Date of Electronic Publication: 2021 Jan 25.